Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly To

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Clinical Medicine|February 14, 2019
Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in <i>Mycobacterium tuberculosis</i> InfectionStephen Cerni, Dylan Shafer, Kimberly To, et al.
Journal of Clinical Medicine|August 13, 2020
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: <i>Mycobacterium avium</i> and <i>Mycobacterium abscessus</i>Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Journal of Clinical Medicine|January 1, 2020
Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially <i>Mycobacterium tuberculosis</i>Steve Ferlita, Aram Yegiazaryan, Navid Noori, et al.
Proceedings. Biological Sciences|November 16, 2018
Neonatal mice exposed to a high-fat diet <i>in utero</i> influence the behaviour of their nursing damMarine Baptissart, Harold E Lamb, Kimberly To, et al.
BMC Bioinformatics|March 7, 2018
ToxPi Graphical User Interface 2.0: Dynamic exploration, visualization, and sharing of integrated data modelsSkylar W Marvel, Kimberly To, Fabian A Grimm, et al.
Biomolecular Concepts|June 1, 2021
Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of <i>Mycobacterium tuberculosis</i> infectionRuoqiong Cao, Kimberly To, Nala Kachour, et al.
Biomolecular Concepts|May 9, 2021
The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against <i>Mycobacterium bovis</i> BCG Strain in Individuals with Type 2 DiabetesKimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Frontiers in Immunology|September 25, 2020
Cyclic Peptide [R<sub>4</sub>W<sub>4</sub>] in Improving the Ability of First-Line Antibiotics to Inhibit <i>Mycobacterium tuberculosis</i> Inside <i>in vitro</i> Human GranulomasJoshua Hernandez, David Ashley, Ruoqiong Cao, et al.
Journal of Clinical Medicine|July 3, 2020
Antimycobacterial Effects of Everolimus in a Human Granuloma ModelDavid Ashley, Joshua Hernandez, Ruoqiong Cao, et al.
Journal of Clinical Medicine|October 2, 2019
Elucidating the Efficacy of the Bacille Calmette-Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal GlutathioneRachel Abrahem, Ruoqiong Cao, Brittanie Robinson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|February 14, 2019
Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in <i>Mycobacterium tuberculosis</i> InfectionStephen Cerni, Dylan Shafer, Kimberly To, et al.
Journal of Clinical Medicine|August 13, 2020
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: <i>Mycobacterium avium</i> and <i>Mycobacterium abscessus</i>Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Journal of Clinical Medicine|January 1, 2020
Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially <i>Mycobacterium tuberculosis</i>Steve Ferlita, Aram Yegiazaryan, Navid Noori, et al.
Proceedings. Biological Sciences|November 16, 2018
Neonatal mice exposed to a high-fat diet <i>in utero</i> influence the behaviour of their nursing damMarine Baptissart, Harold E Lamb, Kimberly To, et al.
BMC Bioinformatics|March 7, 2018
ToxPi Graphical User Interface 2.0: Dynamic exploration, visualization, and sharing of integrated data modelsSkylar W Marvel, Kimberly To, Fabian A Grimm, et al.
Biomolecular Concepts|June 1, 2021
Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of <i>Mycobacterium tuberculosis</i> infectionRuoqiong Cao, Kimberly To, Nala Kachour, et al.
Biomolecular Concepts|May 9, 2021
The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against <i>Mycobacterium bovis</i> BCG Strain in Individuals with Type 2 DiabetesKimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Frontiers in Immunology|September 25, 2020
Cyclic Peptide [R<sub>4</sub>W<sub>4</sub>] in Improving the Ability of First-Line Antibiotics to Inhibit <i>Mycobacterium tuberculosis</i> Inside <i>in vitro</i> Human GranulomasJoshua Hernandez, David Ashley, Ruoqiong Cao, et al.
Journal of Clinical Medicine|July 3, 2020
Antimycobacterial Effects of Everolimus in a Human Granuloma ModelDavid Ashley, Joshua Hernandez, Ruoqiong Cao, et al.
Journal of Clinical Medicine|October 2, 2019
Elucidating the Efficacy of the Bacille Calmette-Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal GlutathioneRachel Abrahem, Ruoqiong Cao, Brittanie Robinson, et al.
Pageof 2